Active Ingredient History
Etoricoxib, sold under the brand name Arcoxia, is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Pain (Phase 3)
Achilles Tendon (Phase 4)
Acute Pain (Phase 4)
Analgesia ()
Anterior Cruciate Ligament Injuries (Phase 4)
Arthritis, Gouty (Phase 2)
Arthritis, Rheumatoid (Phase 4)
Arthroplasty (Phase 3)
Arthroscopy (Phase 4)
Axial Spondyloarthritis (Phase 4)
Back Pain (Phase 4)
Blood Loss, Surgical (Phase 3)
Bone Neoplasms (Phase 2)
Brachial Plexus Block (Phase 3)
Causalgia (Phase 2)
Contusions (Phase 4)
Drugs, Investigational (Phase 3)
Dysmenorrhea (Phase 3)
Etoricoxib (Phase 4)
Fasting (Phase 4)
Fibromyalgia (Phase 4)
Fluorouracil (Phase 4)
General Surgery (Phase 3)
Gout (Phase 4)
Hallux Valgus (Phase 4)
Headache (Phase 4)
Healthy Volunteers (Phase 1)
HIV (Phase 2)
Hysterectomy (Phase 3)
Laparoscopy (Phase 4)
Low Back Pain (Phase 4)
Myalgia (Phase 1)
Neuralgia (Phase 4)
Neuralgia, Postherpetic (Phase 4)
Ossification, Heterotopic (Phase 4)
Osteoarthritis (Phase 4)
Osteoarthritis, Hip (Phase 3)
Osteoarthritis, Knee (Phase 3)
Osteoarthropathy, Primary Hypertrophic (Phase 3)
Ovarian Diseases (Phase 4)
Ovariectomy (Phase 3)
Oxygen (Phase 4)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Periodontitis (Phase 4)
Peripheral Nerve Injuries (Phase 2)
Pharmacokinetics (Early Phase 1)
Polyneuropathies (Phase 2)
Prostatic Neoplasms (Phase 2)
Radiculopathy (Phase 2)
Saliva (Phase 4)
Salpingectomy (Phase 3)
Shoulder Injuries (Phase 3)
Spondylitis, Ankylosing (Phase 3)
Sprains and Strains (Phase 4)
Superoxide Dismutase (Phase 4)
Surgical Wound (Phase 4)
Therapeutic Equivalency (Phase 1)
Thoracic Surgery (Phase 3)
Tonsillectomy (Phase 3)
Tooth (Phase 3)
Tooth Extraction (Phase 4)
Tuberculosis (Phase 1)
Vitiligo (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue